Literature DB >> 17014939

Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.

John Treanor1, Hulin Wu, Hua Liang, David J Topham.   

Abstract

The kinetics and frequency of the primary response to human smallpox vaccine was compared to that among subjects re-vaccinated within the last 2 years, or after several decades. Vaccination induced local and systemic reactions that were mildest in the distant cohort and more severe in the primary vaccinees. The timing of IFN-gamma responses was similar in all three groups, but of higher frequency in the primary vaccinees. Responses to vaccinia re-immunization between those immunized <2 years ago and those immunized >10 years ago were not significantly different. Neutralizing antibodies were boosted in all groups, with the highest titers observed among the distant cohort. However, the antibody and IFN-gamma responses did not correlate strongly with the local reactions at the vaccine site. This suggests that local immune events in the tissue are distinct from the parameters measured in the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014939     DOI: 10.1016/j.vaccine.2006.06.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses.

Authors:  Kristin Scheible; Gang Zhang; Jane Baer; Mitra Azadniv; Kris Lambert; Gloria Pryhuber; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

2.  In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.

Authors:  Joshua D Brody; Weiyun Z Ai; Debra K Czerwinski; James A Torchia; Mia Levy; Ranjana H Advani; Youn H Kim; Richard T Hoppe; Susan J Knox; Lewis K Shin; Irene Wapnir; Robert J Tibshirani; Ronald Levy
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

3.  Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.

Authors:  Pamela T Wong; Su He Wang; Susan Ciotti; Paul E Makidon; Douglas M Smith; Yongyi Fan; Charles F Schuler; James R Baker
Journal:  Mol Pharm       Date:  2013-12-13       Impact factor: 4.939

4.  Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination.

Authors:  Jenna E Ryan; Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  J Immunol Methods       Date:  2008-11-25       Impact factor: 2.303

5.  Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; Jamila Elhmouzi-Younes; Simon Delandre; Inana Namet; Pierre Rosenbaum; Nathalie Dereuddre-Bosquet; Frédéric Martinon; Antonio Cosma; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  Sci Rep       Date:  2018-02-15       Impact factor: 4.379

6.  Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Authors:  Claire M Midgley; Mike M Putz; Jonathan N Weber; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

7.  Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

Authors:  James A Wiley; Laura E Richert; Steve D Swain; Ann Harmsen; Dale L Barnard; Troy D Randall; Mark Jutila; Trevor Douglas; Chris Broomell; Mark Young; Allen Harmsen
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.